SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-19-008434
Filing Date
2019-07-23
Accepted
2019-07-23 17:12:42
Documents
4
Period of Report
2019-07-26
Effectiveness Date
2019-07-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_july262019.htm DEF 14A 1288156
2 IMAGE sig1.jpg GRAPHIC 3888
3 IMAGE sig2.jpg GRAPHIC 3503
4 IMAGE vtgnlogo.jpg GRAPHIC 6979
  Complete submission text file 0001654954-19-008434.txt   1309478
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37761 | Film No.: 19968433
SIC: 2834 Pharmaceutical Preparations